PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-39 Cr | ₹-441 Cr | ₹-422 Cr | ₹818 Cr | ₹794 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-39 Cr |
| Mar2025 | ₹-441 Cr |
| Mar2024 | ₹-422 Cr |
| Mar2023 | ₹818 Cr |
| Mar2022 | ₹794 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-39 Cr | Negative | |
| Mar2025 | ₹-441 Cr | Negative | |
| Mar2024 | ₹-422 Cr | Negative | |
| Mar2023 | ₹818 Cr | 2.97 | |
| Mar2022 | ₹794 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹25,407.9 Cr | -3.4% | -9.2% | 0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -3.4% |
-9.2% |
0.4% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses